Factor h fragment for use as an anti-angiogenic agent

The invention relates to a complement factor H fragment for use in the therapy and/or prophylaxis of a disease involving neovascularization. POC in vivo in a choroidal neovascularization model

Keywords: Dry AMD - neovascularization
Patent Application number: PRIO : 15 63465
PCT/FR2016/053689
Inventors:
Toufik ABACHEFrédéric MASCARELLIVirginie DINETSylvie JORIEUX

Reference:

BIO14280-T1

Business Developper
contact
Anne COCHI
Anne COCHI
Business Development Manager
Patent filling date: 30-12-2015

You might also be interested in